The DOI matches its Crossref record; 556 of the 558 references it cites were found in a registry or an index.
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Open accessAbstract
Patients with atrial fibrillation and coronary artery disease . . . . . . . . .1647 Cardioversion in a NOAC-treated patient . . . . . . . . . . . . . . . . . . . . . . . .1651 AF patients presenting with acute stroke while on NOACs . . . . . . . .1652 NOACs in advanced age and frailty . . . . . . . . . . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Such switch is very common in the hospital setting, mostly as part of periprocedural bridging [24].”
From Overall performance of a drug–drug interaction clinical decision support system: quantitative evaluation and end-user survey (2022) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Self-citationHindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
Self-citationIbanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728
Self-citationRivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
A global clinical measure of fitness and frailty in elderly people
Rockwood, K. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050051 · Cited by 8,968
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Self-citationRoffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
Self-citationPowers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K. J., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B. L., et al. (2019) · Stroke · doi:10.1161/str.0000000000000211 · Cited by 7,957
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz425 · Cited by 7,166
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
Self-citation2017 ESC/EACTS Guidelines for the management of valvular heart disease
Baumgartner, H., Falk, V., Bax, J. J., Bonis, M. D., Hamm, C. W., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Muñoz, D. R., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx391 · Cited by 6,356
Edoxaban versus warfarin in patients with atrial fibrillation
Giugliano, R. P., Ruff, C. T., Braunwald, E., Murphy, S. A., Wiviott, S. D., Halperin, J. L., Waldo, A. L., Ezekowitz, M. D., Weitz, J. I., Špinar, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310907 · Cited by 5,164
Ruff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., Parkhomenko, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62343-0 · Cited by 5,051
Self-citationCollet, J.-P., Thiele, H., Barbato, E., Barthélémy, O., Bauersachs, J., Bhatt, D. L., Dendale, P., Dorobantu, M., Edvardsen, T., Folliguet, T., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa575 · Cited by 5,037
Schulman, S., & Kearon, C. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01204.x · Cited by 5,025
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
The GUSTO Investigators (1993) · New England Journal of Medicine · doi:10.1056/nejm199309023291001 · Cited by 4,042
Schulman, S., Angerås, U., Bergqvist, D., ERIKSSON, B., Lassen, M. R., & FISHER, W. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03678.x · Cited by 3,761
Falls in older people: epidemiology, risk factors and strategies for prevention
Rubenstein, L. Z. (2006) · Age and Ageing · doi:10.1093/ageing/afl084 · Cited by 3,310
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007903 · Cited by 3,237
Valgimigli, M., Bueno, H., Byrne, R. A., Collet, J., Costa, F., Jeppsson, A., Jüni, P., Kastrati, A., Kolh, P. H., Mauri, L., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx419 · Cited by 3,041
Self-citationCalkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.05.012 · Cited by 2,794
Self-citationJanuary, C. T., Wann, L. S., Calkins, H., Chen, L. Y., Cigarroa, J. E., Cleveland, J. C., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., Furie, K. L., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000665 · Cited by 2,744
Self-citationZamorano, J. L., Lancellotti, P., Muñoz, D. R., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw211 · Cited by 2,655
Self-citationDabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
Schulman, S., Kearon, C., Kakkar, A. K., Mismetti, P., Schellong, S., Eriksson, H., Baanstra, D., Schnee, J. M., & Goldhaber, S. Z. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906598 · Cited by 2,572
Apixaban in patients with atrial fibrillation
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483
Self-citationRivaroxaban with or without aspirin in stable cardiovascular disease
Eikelboom, J. W., Connolly, S. J., Bosch, J., Dagenais, G. R., Hart, R. G., Shestakovska, O., Diaz, R., Alings, M., Lonn, E. M., Anand, S. S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709118 · Cited by 2,438
Büller (2012) · doi:10.1056/nejmoa1113572 · Cited by 2,353
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
Agnelli, G., Buller, H. R., Cohen, A., Curto, M., Gallus, A. S., Johnson, M., Masiukiewicz, U., Pak, R., Thompson, J., Raskob, G. E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302507 · Cited by 2,324
Tinetti, M. E., Baker, D. I., McAvay, G., Claus, E. B., Garrett, P., Gottschalk, M., Koch, M. L., Trainor, K. M., & Horwitz, R. I. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409293311301 · Cited by 2,160
Steffel, J., Verhamme, P., Potpara, T. S., Albaladejo, P., Antz, M., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy136 · Cited by 2,123
Self-citationLong-term use of ticagrelor in patients with prior myocardial infarction
Bonaca, M. P., Bhatt, D. L., Cohen, M., Steg, P. G., Storey, R. F., Jensen, E. C., Magnani, G., Bansilal, S., Fish, M. P., Im, K., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500857 · Cited by 1,999
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Mauri, L., Kereiakes, D. J., Yeh, R. W., Driscoll-Shempp, P., Cutlip, D. E., Steg, P. G., Normand, S.-L. T., Braunwald, E., Wiviott, S. D., Cohen, D. J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409312 · Cited by 1,928
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
Mega, J. L., Braunwald, E., Wiviott, S. D., Bassand, J., Bhatt, D. L., Bode, C., Burton, P. B. J., Cohen, M. C., Cook‐Bruns, N., Fox, K. A. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1112277 · Cited by 1,923
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
The Hokusai-VTE Investigators (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306638 · Cited by 1,869
Zamorano, J. L., Lancellotti, P., Muñoz, D. R., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,797
Self-citationEdoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Raskob, G. E., van Es, N., Verhamme, P. B., Carrier, M., Nisio, M. D., Garcia, D. A., GROSSO, M. A., Kakkar, A. K., Kovacs, M. J., Mercuri, M. F., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1711948 · Cited by 1,633
Prevention of bleeding in patients with atrial fibrillation undergoing PCI
Gibson, C. M., Mehran, R., Bode, C., Halperin, J., Verheugt, F. W., Wildgoose, P., Birmingham, M., Ianus, J., Burton, P., van Eickels, M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1611594 · Cited by 1,590
Self-citationDabigatran versus warfarin in patients with mechanical heart valves
Eikelboom, J. W., Connolly, S. J., Brueckmann, M., Granger, C. B., Kappetein, A. P., Mack, M. J., Blatchford, J., Devenny, K., Friedman, J., Guiver, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300615 · Cited by 1,506
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
Eriksson, B. I., Borris, L. C., Friedman, R. J., Haas, S., Huisman, M. V., Kakkar, A. K., Bandel, T. J., Beckmann, H., Muehlhofer, E., Misselwitz, F., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800374 · Cited by 1,433
Obesity and the risk of new-onset atrial fibrillation
Wang, T. J. (2004) · JAMA · doi:10.1001/jama.292.20.2471 · Cited by 1,427
Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation
Cannon, C. P., Bhatt, D. L., Oldgren, J., Lip, G. Y. H., Ellis, S. G., Kimura, T., Maeng, M., Merkely, B., Zeymer, U., Gropper, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708454 · Cited by 1,383
Self-citationStangier, J., Haertter, S., Liesenfeld, K., Wienen, W., Feuring, M., Clemens, A., & van Ryn, J. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-11-0758 · Cited by 1,378
Young, A., Marshall, A., Thirlwall, J., Chapman, O., Lokare, A., Hill, C. S., Hale, D., Dunn, J., Lyman, G. H., Hutchinson, C. E., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.8034 · Cited by 1,373
Apixaban for Extended Treatment of Venous Thromboembolism
Agnelli, G., Buller, H. R., Cohen, A., Curto, M., Gallus, A. S., Johnson, M., Porcari, A., Raskob, G. E., & Weitz, J. I. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1207541 · Cited by 1,366
Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate
Eerenberg, E. S., Kamphuisen, P. W., Sijpkens, M. K., Meijers, J. C. M., Buller, H. R., & Levi, M. M. (2011) · Circulation · doi:10.1161/circulationaha.111.029017 · Cited by 1,353
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
Lassen, M. R., Ageno, W., Borris, L. C., Lieberman, J. R., Rosencher, N., Bandel, T. J., Misselwitz, F., & Turpie, A. G. G. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa076016 · Cited by 1,295
Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation
Lopes, R. D., Heizer, G., Aronson, R., Vora, A. N., Massaro, T., Mehran, R., Goodman, S. G., Windecker, S., Darius, H., Li, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1817083 · Cited by 1,228
Self-citationCalkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · EP Europace · doi:10.1093/europace/eux274 · Cited by 1,203
Self-citationPerioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
Douketis, J. D., Spyropoulos, A. C., Kaatz, S., Becker, R. C., Caprini, J. A., Dunn, A. S., Garcia, D. A., Jacobson, A., Jaffer, A. K., Kong, D. F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501035 · Cited by 1,184
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
Pollack, C. V., Reilly, P. A., van Ryn, J., Eikelboom, J. W., Glund, S., Bernstein, R. A., Dubiel, R., Huisman, M. V., Hylek, E. M., Kam, C. W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707278 · Cited by 1,148
Heidbüchel, H., Verhamme, P. B., Alings, M., Antz, M., Diener, H., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. F. (2015) · EP Europace · doi:10.1093/europace/euv309 · Cited by 1,129
Self-citationApixaban for the Treatment of Venous Thromboembolism Associated with Cancer
Agnelli, G., Becattini, C., Meyer, G., Martín, A. J. M., Huisman, M. V., Connors, J. M., Cohen, A. T., Bauersachs, R. M., Brenner, B., Torbicki, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915103 · Cited by 1,088
Eikelboom, J. W., Wallentin, L., Connolly, S. J., Ezekowitz, M., Healey, J. S., Oldgren, J., Yang, S., Alings, M., Kaatz, S., Hohnloser, S. H., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.004747 · Cited by 1,081
Self-citationKakkar, A. K., Brenner, B., Dahl, O. E., Eriksson, B. I., Mouret, P., Muntz, J., Soglian, A. G., Pap, A. F., Misselwitz, F., & Haas, S. K. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60880-6 · Cited by 1,069
Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update
An, S. J., Kim, T. J., & Yoon, B. W. (2017) · Journal of Stroke · doi:10.5853/jos.2016.00864 · Cited by 1,049
Dementia and Cognitive Impairment
Hugo, J., & Ganguli, M. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.04.001 · Cited by 990
Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
Schulman, S., Kearon, C., Kakkar, A. K., Schellong, S., Eriksson, H., Baanstra, D., Kvamme, A. M., Friedman, J., Mismetti, P., & Goldhaber, S. Z. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1113697 · Cited by 983
Turpie, A. G., Lassen, M. R., Davidson, B. L., Bauer, K. A., Gent, M., Kwong, L. M., Cushner, F. D., Lotke, P. A., Berkowitz, S. D., Bandel, T. J., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60734-0 · Cited by 978
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
Connolly, S. J., Crowther, M. A., Eikelboom, J. W., Gibson, C. M., Curnutte, J. T., Lawrence, J. H., Yue, P., Bronson, M. D., Lu, G., Conley, P. B., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1814051 · Cited by 977
Eriksson, B. I., Dahl, O. E., Rosencher, N., Kurth, A. A., van Dijk, C. N., Frostick, S. P., Kälebo, P., Christiansen, A. V., Hantel, S., Hettiarachchi, R., et al. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02748.x · Cited by 976
Aspirin in Patients Undergoing Noncardiac Surgery
Devereaux, P. J., Mrkobrada, M., Sessler, D. I., Leslie, K., Alonso‐Coello, P., Kurz, A. M., Villar, J. C., Sigamani, A., Biccard, B. M., Meyhoff, C. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401105 · Cited by 940
Stroke and bleeding in atrial fibrillation with chronic kidney disease
Olesen, J. B., Lip, G. Y. H., Kamper, A.-L., Hommel, K., Køber, L., Lane, D. A., Lindhardsen, J., Gislason, G. H., & Torp-Pedersen, C. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105594 · Cited by 930
Self-citationA brief clinical instrument to classify frailty in elderly people
Rockwood, K. J., Stadnyk, K., MacKnight, C., McDowell, I., Hébert, R., & Hogan, D. B. (1999) · The Lancet · doi:10.1016/s0140-6736(98)04402-x · Cited by 914
Stangier, J., Rathgen, K., Stähle, H., Ganßer, D., & Roth, W. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02899.x · Cited by 885
Reilly, P. A., Lehr, T., Haertter, S., Connolly, S. J., Yusuf, S., Eikelboom, J. W., Ezekowitz, M. D., Nehmiz, G., Wang, S., & Wallentin, L. C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.104 · Cited by 838
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk
Urban, P. M., Meredith, I. T., Abizaid, A., Pocock, S., Carrié, D., Naber, C. K., Lipiecki, J., Richardt, G., Íñiguez, A., Brunel, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503943 · Cited by 824
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome
Pengo, V., Denas, G., Zoppellaro, G., Jose, S. P., Hoxha, A., Ruffatti, A., Andreoli, L., Tincani, A., Cenci, C., Prisco, D., et al. (2018) · Blood · doi:10.1182/blood-2018-04-848333 · Cited by 822
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
Connolly, S. J., Milling, T. J., Eikelboom, J. W., Gibson, C. M., Curnutte, J. T., Gold, A., Bronson, M. D., Lu, G., Conley, P. B., Verhamme, P. B., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607887 · Cited by 812
Heidbuchel, H., Verhamme, P., Alings, M., Antz, M., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. (2013) · Europace · doi:10.1093/europace/eut083 · Cited by 792
Self-citationRivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
Weitz, J. I., Lensing, A. W. A., Prins, M. H., Bauersachs, R., Beyer-Westendorf, J., Bounameaux, H., Brighton, T. A., Cohen, A. T., Davidson, B. L., Decousus, H., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1700518 · Cited by 787
Abed, H. S., Wittert, G. A., Leong, D. P., Shirazi, M. G., Bahrami, B., Middeldorp, M. E., Lorimer, M. F., Lau, D. H., Antic, N. A., Brooks, A. G., et al. (2013) · JAMA · doi:10.1001/jama.2013.280521 · Cited by 776
Stangier, J., Rathgen, K., Stähle, H., & Mazur, D. (2010) · Clinical Pharmacokinetics · doi:10.2165/11318170-000000000-00000 · Cited by 720
Vranckx, P., Valgimigli, M., Eckardt, L., Tijssen, J. G. P., Lewalter, T., Gargiulo, G., Batushkin, V., Campo, G. C., Lysak, Z., Ip, V., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31872-0 · Cited by 712
Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2017.08.001 · Cited by 709
Self-citationThe Metabolism and Disposition of the Oral Direct Thrombin Inhibitor, Dabigatran, in Humans
Blech, S., Ebner, T., Ludwig-Schwellinger, E., Stangier, J., & Roth, W. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.019083 · Cited by 688
Osmancik, P. P., Heřman, D., Neužil, P., Hála, P., Táborský, M., Kala, P., Poloczek, M., Šťásek, J., Haman, L., Branny, M., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.067 · Cited by 674
Stangier, J. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847050-00001 · Cited by 659
Shen, A. Y., Yao, J. F., Brar, S. S., Jorgensen, M. B., & Chen, W. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.098 · Cited by 657
Kubitza, D., Becka, M., Voith, B., Zuehlsdorf, M., & Wensing, G. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.06.011 · Cited by 646
Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation
Hori, M., Matsumoto, M., Tanahashi, N., Momomura, S., Uchiyama, S., Goto, S., Izumi, T., Koretsune, Y., Kajikawa, M., Kato, M. C., et al. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0454 · Cited by 645
Graham, D. J., Reichman, M. E., Wernecke, M., Zhang, R., Southworth, M. R., Levenson, M., Sheu, T.-C., Mott, K., Goulding, M. R., Houstoun, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.012061 · Cited by 644
Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
Mueck, W., Stampfuss, J. J., Kubitza, D., & Becka, M. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0100-7 · Cited by 634
Sibbing, D., Aradi, D., Jacobshagen, C., Gross, L., Trenk, D., Geisler, T., Orban, M., Hadamitzky, M., Merkely, B., Kiss, R. G., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32155-4 · Cited by 615
Glomerular hemodynamics in severe obesity
Chagnac, A., Weinstein, T., Korzets, A., Ramadan, E., Hirsch, J. A., & Gafter, U. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.5.f817 · Cited by 613
Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans
Raghavan, N., Frost, C. E., Yu, Z., He, K., Zhang, H., Humphreys, W. G., Pinto, D. J. P., Chen, S.-Y., Bonacorsi, S. J., Wong, P. C., et al. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023143 · Cited by 610
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
Yasuda, S., Kaikita, K., Akao, M., Ako, J., Matoba, T., Nakamura, M., Miyauchi, K., Hagiwara, N., Kimura, K., Hirayama, A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1904143 · Cited by 585
Dichgans, M., & Leys, D. (2017) · Circulation Research · doi:10.1161/circresaha.116.308426 · Cited by 581
Hohnloser, S. H., Hijazi, Z., Thomas, L., Alexander, J. H., Amerena, J., Hanna, M., Keltai, M., Lanas, F., Lopes, R. D., Lopez-Sendon, J., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs274 · Cited by 574
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement
Dangas, G., Tijssen, J. G. P., Wöhrle, J., Søndergaard, L., Gilard, M., Möllmann, H., Makkar, R., Herrmann, H. C., Giustino, G., Baldus, S. E., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911425 · Cited by 562
Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin
Healey, J. S., Eikelboom, J. W., Douketis, J. D., Wallentin, L. C., Oldgren, J., Yang, S., Themeles, E., Heidbüchel, H., Avezum, Á., Reilly, P. A., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.090464 · Cited by 540
Self-citationPerioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant
Douketis, J. D., Spyropoulos, A. C., Duncan, J. M., Carrier, M., Gal, G. L., Tafur, A. J., Vanassche, T., Verhamme, P. B., Shivakumar, S., Gross, P. L., et al. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.2431 · Cited by 538
Self-citationMan‐Son‐Hing, M., Nichol, G., Lau, A., & Laupacis, A. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.7.677 · Cited by 537
Alonso, Á., Agarwal, S. K., Soliman, E. Z., Ambrose, M., Chamberlain, A. M., Prineas, R. J., & Folsom, A. R. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.05.010 · Cited by 527
Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · EP Europace · doi:10.1093/europace/eux275 · Cited by 521
Self-citationEriksson, B. I., Quinlan, D. J., & Weitz, J. I. (2008) · Clinical Pharmacokinetics · doi:10.2165/0003088-200948010-00001 · Cited by 520
Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes
Steinberg, B. A., Shrader, P., Thomas, L. E., Ansell, J., Fonarow, G. C., Gersh, B. J., Kowey, P. R., Mahaffey, K. W., Naccarelli, G. V., Reiffel, J. A., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.966 · Cited by 500
Siontis, K. C., Zhang, X., Eckard, A., Bhave, N. M., Schaubel, D. E., He, K., Tilea, A. M., Stack, A. G., Balkrishnan, R., Yao, X., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.035418 · Cited by 499
Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis
Lavie, C. J., Pandey, A., Lau, D. H., Alpert, M., & Sanders, P. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.002 · Cited by 490
Biase, L. D., Burkhardt, J. D., Santangeli, P., Mohanty, P. K., Sánchez, J., Horton, R., Gallinghouse, G. J., Themistoclakis, S., Rossillo, A., Lakkireddy, D., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.006426 · Cited by 485
Dans, A. L., Connolly, S. J., Wallentin, L., Yang, S., Nakamya, J., Brueckmann, M., Ezekowitz, M., Oldgren, J., Eikelboom, J. W., Reilly, P. A., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.115386 · Cited by 484
Self-citationApostolakis, S. Z., Sullivan, R. M., Olshansky, B., & Lip, G. Y. H. (2013) · CHEST Journal · doi:10.1378/chest.13-0054 · Cited by 480
Self-citationBovill, E. G., Terrin, M. L., Stump, D. C., Berke, A. D., Frederick, M., Collen, D., Feit, F., Gore, J. M., Hillis, L. D., Lambrew, C. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-4-256 · Cited by 480
for the SIF-AIGO-FIMMG Group, Scarpignato, C., on behalf of the Italian Society of Pharmacology, T. I. A. O. H. G., Gatta, L., Zullo, A., & Blandizzi, C. (2016) · BMC Medicine · doi:10.1186/s12916-016-0718-z · Cited by 469
APPRAISE Steering Committee and Investigators (2009) · Circulation · doi:10.1161/circulationaha.108.832139 · Cited by 458
Soliman, E. Z., Prineas, R. J., Go, A. S., Xie, D., Lash, J. P., Rahman, M., OJO, A. O., Teal, V. L., Jensvold, N. G., Robinson, N. L., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.03.027 · Cited by 456
Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants
Cuker, A. C., Siegal, D. M., Crowther, M. A., & Garcia, D. A. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.065 · Cited by 455
Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure
Hesdorffer, D. C., Benn, E. K. T., Cascino, G. D., & Hauser, W. A. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01945.x · Cited by 454
Ogata, K., Mendell‐Harary, J., Tachibana, M., Masumoto, H., Oguma, T., Kojima, M., & Kunitada, S. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009351883 · Cited by 453
Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH
Martin, K. A., Beyer‐Westendorf, J., Davidson, B. L., Huisman, M. V., Sandset, P. M., & Moll, S. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13323 · Cited by 450
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19
Nadkarni, G. N., Lala, A., Bagiella, E., Chang, H. L., Moreno, P., Pujadas, E., Arvind, V., Bose, S., Charney, A. W., Chen, M. D., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.041 · Cited by 450
Go, A. S., Fang, M. C., Udaltsova, N. V., Chang, Y., Pomernacki, N. K., Borowsky, L. H., & Singer, D. E. (2009) · Circulation · doi:10.1161/circulationaha.108.816082 · Cited by 447
Halperin, J. L., Hankey, G. J., WOJDYLA, D. M., Piccini, J. P., Lokhnygina, Y. V., Patel, M. R., BREITHARDT, G. E., Singer, D. E., Becker, R. C., Hacke, W., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005008 · Cited by 433
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
Calkins, H. G., Willems, S., Gerstenfeld, E. P., Verma, A., SCHILLING, R. J., Hohnloser, S. H., Okumura, K., Serota, H., Nordaby, M., Guiver, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701005 · Cited by 432
Yao, X., Abraham, N. S., Sangaralingham, L. R., Bellolio, F., McBane, R. D., Shah, N. D., & Noseworthy, P. A. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003725 · Cited by 430
Stangier, J., Stähle, H., Rathgen, K., & Fuhr, R. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847010-00005 · Cited by 427
Cappato, R., Marchlinski, F. E., Hohnloser, S. H., Naccarelli, G. V., Xiang, J., Wilber, D. J., Ma, C.-S., Hess, S., Wells, D. S., Juang, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv177 · Cited by 422
Valgimigli, M., Bueno, H., Byrne, R. A., Collet, J., Costa, F., Jeppsson, A., Jüni, P., Kastrati, A., Kolh, P. H., Mauri, L., et al. (2017) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezx334 · Cited by 421
Self-citationEzekowitz, M. D., Reilly, P. A., Nehmiz, G., Simmers, T. A., Nagarakanti, R., Parcham-Azad, K., Pedersen, K. E., Lionetti, D. A., Stangier, J., & Wallentin, L. C. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.06.034 · Cited by 420
Tomaselli, G. F., Mahaffey, K. W., Cuker, A. C., Dobesh, P. P., Doherty, J. U., Eikelboom, J. W., Florido, R., Gluckman, T. J., Hucker, W. J., Mehran, R., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.053 · Cited by 420
2017 EACTS Guidelines on perioperative medication in adult cardiac surgery
Sousa‐Uva, M., Head, S. J., Milojevic, M., Collet, J., Landoni, G., Castellà, M., Dunning, J., Guðbjartsson, T., Linker, N., Sandoval, E., et al. (2017) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezx314 · Cited by 415
Epileptic seizures after a first stroke: the Oxfordshire community stroke project
Burn, J., Dennis, M. S., Bamford, J., Sandercock, P. A., Wade, D. T., & Warlow, C. (1997) · BMJ · doi:10.1136/bmj.315.7122.1582 · Cited by 409
Beyer‐Westendorf, J., Förster, K., Pannach, S., Ebertz, F., Gelbricht, V., Thieme, C., Michalski, F., Köhler, C. U., Werth, S., Şahin, K., et al. (2014) · Blood · doi:10.1182/blood-2014-03-563577 · Cited by 408
Ruff, C. T., Giugliano, R. P., Braunwald, E., Morrow, D. A., Murphy, S. A., Kuder, J. F., Deenadayalu, N., Jarolim, P., Betcher, J., Shi, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61943-7 · Cited by 405
Dahl, O. E., Huo, M. H., Kurth, A. A., Hantel, S., Hermansson, K., Schnee, J. M., Friedman, R. J., Eriksson, B. I., & for the RE-NOVATE II Study Group (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-10-0679 · Cited by 404
Abed, H. S., Samuel, C. S., Lau, D. H., Kelly, D. J., Royce, S. G., Alasady, M., Mahajan, R., Kuklik, P., Zhang, Y., Brooks, A. G., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.08.043 · Cited by 401
Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery
Gillinov, A. M., Bagiella, E., Moskowitz, A. J., Raiten, J. M., Groh, M. A., Bowdish, M. E., Ailawadi, G., Kirkwood, K. A., Perrault, L. P., Parides, M. K., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602002 · Cited by 398
Chang, S., Chou, I., Yeh, Y., Chiou, M., Wen, M., Kuo, C.-T., See, L., & Kuo, C. (2017) · JAMA · doi:10.1001/jama.2017.13883 · Cited by 397
Gosselin, R. C., Adcock, D. M., Bates, S. M., Douxfils, J., Favaloro, E. J., Gouin‐Thibault, I., Guillermo, C., Kawai, Y., Lindhoff‐Last, E., & Kitchen, S. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1627480 · Cited by 395
Collet, J., & Thiele, H. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa624 · Cited by 395
Varenne, O., Cook, S., Sidéris, G., Kedev, S. A., Cuisset, T., Carrié, D., Hovasse, T., Garot, P., Mahmoud, R. E., Spaulding, C. M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32713-7 · Cited by 392
Self-citationBeyer‐Westendorf, J., Gelbricht, V., Förster, K., Ebertz, F., Köhler, C. U., Werth, S., Kuhlisch, E., Stange, T., Thieme, C., Daschkow, K., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht557 · Cited by 387
Douxfils, J., Ageno, W., Samama, C. M., Lessire, S., Cate, H. T., Verhamme, P. B., Dogné, J.-M., & Mullier, F. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13912 · Cited by 384
Mueck, W., Kubitza, D., & Becka, M. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12075 · Cited by 379
Halvorsen, S., Atar, D., Yang, H., Caterina, R. D., Erol, Ç., Garcia, D., Granger, C. B., Hanna, M., Held, C., Husted, S., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu046 · Cited by 377
Self-citationAnticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation
Nijenhuis, V. J., Brouwer, J., Delewi, R., Hermanides, R. S., Holvoet, W., Dubois, C., Frambach, P., Bruyne, B. D., van Houwelingen, G. K., der Heyden, J. A. S. V., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915152 · Cited by 357
Watanabe, H., Watanabe, T., Sasaki, S., Nagai, K., Roden, D. M., & Aizawa, Y. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.06.031 · Cited by 352
Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation
Okumura, K., Akao, M., Yoshida, T., Kawata, M., Okazaki, O., Akashi, S., Eshima, K., Tanizawa, K., Fukuzawa, M., Hayashi, T., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2012883 · Cited by 351
Self-citationTomaselli, G. F., Mahaffey, K. W., Cuker, A. C., Dobesh, P. P., Doherty, J. U., Eikelboom, J. W., Florido, R., Hucker, W. J., Mehran, R., Messe, S. R., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.1085 · Cited by 348
Galovic, M., Döhler, N., Erdélyi‐Canavese, B., Felbecker, A., Siebel, P., Conrad, J., Evers, S., Winklehner, M., von Oertzen, T. J., Haring, H., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30404-0 · Cited by 347
Male, C., Lensing, A. W. A., Palumbo, J. S., Kumar, R., Nurmeev, I. N., Hege, K. M., Bonnet, D., Connor, P., Hooimeijer, H. L., Torres, M. D., et al. (2019) · The Lancet Haematology · doi:10.1016/s2352-3026(19)30219-4 · Cited by 345
Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin
Hylek, E. M., Held, C., Alexander, J. H., Lopes, R. D., De Caterina, R., Wojdyla, D. M., Huber, K., Jansky, P., Steg, P. G., Hanna, M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.549 · Cited by 344
Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment
Burnett, A., Mahan, C. E., Vazquez, S. R., Oertel, L. B., Garcia, D. A., & Ansell, J. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1310-7 · Cited by 343
Shah, M., Tsadok, M. A., Jackevicius, C. A., Essebag, V., Eisenberg, M. J., Rahme, E., Humphries, K. H., Tu, J. V., Behlouli, H., Guo, H., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.004777 · Cited by 340
Kubitza, D., Becka, M., Zuehlsdorf, M., & Mueck, W. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006296058 · Cited by 334
Liesenfeld, K., Lehr, T., Dansirikul, C., Reilly, P., Connolly, S., Ezekowitz, M., Yusuf, S., Wallentin, L., Haertter, S., & Staab, A. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04498.x · Cited by 333
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients
Lip, G. Y. H., Keshishian, A. V., Li, X., Hamilton, M., Masseria, C., Gupta, K. B., Luo, X., Mardekian, J., Friend, K. E., Nadkarni, A., et al. (2018) · Stroke · doi:10.1161/strokeaha.118.020232 · Cited by 333
Self-citationGargiulo, G., Goette, A., Tijssen, J. G. P., Eckardt, L., Lewalter, T., Vranckx, P., & Valgimigli, M. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz732 · Cited by 332
Majeed, A., Ågren, A., Holmström, M., Bruzelius, M., Chaireti, R., Odeberg, J., Hempel, E.-L., Magnusson, M., Frisk, T., & Schulman, S. (2017) · Blood · doi:10.1182/blood-2017-05-782060 · Cited by 330
Mueck, W., Lensing, A. W. A., Agnelli, G., Decousus, H., Prandoni, P., & Misselwitz, F. (2011) · Clinical Pharmacokinetics · doi:10.2165/11595320-000000000-00000 · Cited by 328
Hori, M., Connolly, S. J., Zhu, J., Liu, L., Lau, C., Pais, P. S., Xavier, D., Kim, S. S., Omar, R., Dans, A. L., et al. (2013) · Stroke · doi:10.1161/strokeaha.113.000990 · Cited by 328
Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis
Chan, K. E., Edelman, E. R., Wenger, J., Thadhani, R., & Maddux, F. W. (2015) · Circulation · doi:10.1161/circulationaha.114.014113 · Cited by 326
Impact of dabigatran on a large panel of routine or specific coagulation assays
Robert, S., Chatelain, C., Douxfils, J., Mullier, F., Châtelain, B., & Dogné, J. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-11-0804 · Cited by 325
Zhou, W., Schwarting, S., Illanes, S., Liesz, A., Middelhoff, M. A., Zorn, M., Bendszus, M., Heiland, S., van Ryn, J., & Veltkamp, R. C. (2011) · Stroke · doi:10.1161/strokeaha.111.624650 · Cited by 321
Graham, D. J., Reichman, M. E., Wernecke, M., Hsueh, Y.-H., Izem, R., Southworth, M. R., Wei, Y., Liao, J., Goulding, M. R., Mott, K., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.5954 · Cited by 312
Bae, S., Kim, S. R., Kim, M., Shim, W. J., & Park, S. (2020) · Heart · doi:10.1136/heartjnl-2020-317901 · Cited by 312
Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial Fibrillation
Birman-Deych, E., Radford, M. J., Nilasena, D. S., & Gage, B. F. (2006) · Stroke · doi:10.1161/01.str.0000208294.46968.a4 · Cited by 301
Perioperative/Postoperative Atrial Fibrillation and Risk of Subsequent Stroke and/or Mortality
Lin, M.-H., Kamel, H., Singer, D. E., Wu, Y., Lee, M., & Ovbiagele, B. I. (2019) · Stroke · doi:10.1161/strokeaha.118.023921 · Cited by 298
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve
Guimarães, H. P., Lópes, R. D., Silva, P. G. M. D. B. E., Liporace, I. L., Sampaio, R. O., Tarasoutchi, F., Filho, C. R. H., Patriota, R. D. L. S., Leiria, T. L. L., Lamprea, D., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2029603 · Cited by 295
Stangier, J., Eriksson, B. I., Dahl, O. E., Ahnfelt, L., Nehmiz, G., Stähle, H., Rathgen, K., & Svärd, R. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005274550 · Cited by 294
Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk
Windecker, S., Latib, A., Kedhi, E., Kirtane, A. J., Kandzari, D. E., Mehran, R., Price, M. J., Abizaid, A., Simon, D. I., Worthley, S. G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1910021 · Cited by 294
Healey, J. S., Oldgren, J., Ezekowitz, M. D., Zhu, J., Pais, P., Wang, J., Commerford, P., Janský, P., Avezum, Á., Sigamani, A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30968-0 · Cited by 292
Self-citationKato, E. T., Giugliano, R. P., Ruff, C. T., Koretsune, Y., Yamashita, T., Kiss, R. G., Nordio, F., Murphy, S. A., Kimura, T., Jin, J., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003432 · Cited by 288
Frost, C., Nepal, S., Wang, J., Schuster, A., Byon, W., Boyd, R. A., Yu, Z., Shenker, A., Barrett, Y. C., Mosqueda‐Garcia, R., et al. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12106 · Cited by 286
Bonde, A. N., Lip, G. Y. H., Kamper, A., Hansen, P. R., Lamberts, M., Hommel, K., Hansen, M. L., Gislason, G., Torp-Pedersen, C. T., & Olesen, J. B. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.051 · Cited by 285
Self-citationThe Changing Landscape for Stroke Prevention in AF
Huisman, M. V., Rothman, K. J., Paquette, M., Teutsch, C., Diener, H., Dubner, S., Halperin, J. L., Sheng, C., Zint, K., Elsaesser, A., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.061 · Cited by 280
Self-citationManagement and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin
Majeed, A., Hwang, H.-G., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Wallentin, L. C., Brueckmann, M., Fraessdorf, M., Yusuf, S., & Schulman, S. (2013) · Circulation · doi:10.1161/circulationaha.113.002332 · Cited by 276
Dilemmas in the Management of Atrial Fibrillation in Chronic Kidney Disease
Reinecke, H., Brand, E., Mesters, R. M., Diaeresis]bitz, W.-R. D. S., Fisher, M., Diaeresis]dt, H. P., & Breithardt, G. D. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007111207 · Cited by 271
Self-citationKubitza, D., Becka, M., Roth, A., & Mueck, W. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802361499 · Cited by 270
Upreti, V. V., Wang, J. J. J., Barrett, Y. C., Byon, W., Boyd, R. A., Pursley, J. M., LaCreta, F. P., & Frost, C. E. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12114 · Cited by 270
Incidence and predictors of acute symptomatic seizures after stroke
Beghi, E., D'Alessandro, R., Beretta, S., Consoli, D., Crespi, V., Delaj, L., Gandolfo, C., Greco, G., Neve, A. L., Manfredi, M., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182364878 · Cited by 267
Sherwood, M. W., Douketis, J. D., Patel, M. R., Piccini, J. P., Hellkamp, A. S., Lokhnygina, Y. V., Spyropoulos, A. C., Hankey, G. J., Singer, D. E., Nessel, C. C., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005754 · Cited by 266
Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy
Rowin, E. J., Hausvater, A., Link, M. S., Abt, P., Gionfriddo, W., Wang, W., Rastegar, H., Estes, N. A. M., Maron, M. S., & Maron, B. J. (2017) · Circulation · doi:10.1161/circulationaha.117.029267 · Cited by 262
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
Yasuda, S., & Ogawa, H. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1914049 · Cited by 260
Baglin, T. P., Hillarp, A., Tripodi, A., Elalamy, I., Buller, H. R., & Ageno, W. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12149 · Cited by 255
Kubitza, D., Becka, M., Zuehlsdorf, M., & Mueck, W. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006286904 · Cited by 254
Wilson, D., Ambler, G., Shakeshaft, C., Brown, M. M., Charidimou, A., Salman, R. A., Lip, G. Y. H., Cohen, H., Banerjee, G., Houlden, H., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30145-5 · Cited by 254
Self-citationWang, L., Zhang, D., Raghavan, N., Yao, M., Ma, L., Frost, C. A., Maxwell, B. D., Chen, S.-Y., He, K., Goosen, T. C., et al. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.029694 · Cited by 252
Kim, D., Yang, P., Yu, H. T., Kim, T., Jang, E., Sung, J., Pak, H., Lee, M., Lee, M., Lip, G. Y. H., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz386 · Cited by 252
Self-citationZahir, H., Brown, K. S., Vandell, A. G., Desai, M., Maa, J., Dishy, V., Lomeli, B., Feussner, A., Feng, W., He, L., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.013445 · Cited by 250
Steffel, J., Verhamme, P. B., Potpara, T., Albaladejo, P., Antz, M., Desteghe, L., Hæusler, K. G., Oldgren, J., Reinecke, H., Roldán, V., et al. (2018) · EP Europace · doi:10.1093/europace/euy054 · Cited by 248
Self-citationDouxfils, J., Mullier, F., Loosen, C., Chatelain, C., Châtelain, B., & Dogné, J. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.09.004 · Cited by 247
Old and new oral anticoagulants: Food, herbal medicines and drug interactions
Minno, A. D., Frigerio, B., Spadarella, G., Ravani, A. L., Sansaro, D., Amato, M., Kitzmiller, J. P., Pepi, M., Tremoli, E., & Baldassarre, D. (2017) · Blood Reviews · doi:10.1016/j.blre.2017.02.001 · Cited by 247
Translating the Results of Randomized Trials into Clinical Practice
Hylek, E. M., D’Antonio, J. A., Evans‐Molina, C., Shea, C., Henault, L. E., & Regan, S. (2006) · Stroke · doi:10.1161/01.str.0000209239.71702.ce · Cited by 246
Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi
Robinson, A. A., Trankle, C. R., Eubanks, G. C., Schumann, C. L., Thompson, P., Wallace, R. L., Gottiparthi, S., Ruth, B. K., Kramer, C. M., Salerno, M., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.0652 · Cited by 246
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease
Avezum, Á., Lópes, R. D., Schulte, P. J., Lanas, F. T., Gersh, B. J., Hanna, M., Pais, P., Erol, Ç., Díaz, R., Bahit, M. C., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.014807 · Cited by 245
Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation
Seiffge, D. J., Werring, D. J., Paciaroni, M., Dawson, J., Warach, S. J., Milling, T. J., Engelter, S. T., Fischer, U., & Norrving, B. G. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30356-9 · Cited by 245
Andrade, J. G., Verma, A., Mitchell, L. B., Parkash, R., Leblanc, K., Atzema, C. L., Healey, J. S., Bell, A., Cairns, J. A., Connolly, S. J., et al. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.08.026 · Cited by 242
Godiér, A., Miclot, A., Bonniec, B. L., Durand, M., Fischer, A., Emmerich, J., Marchand‐Leroux, C., Lecompte, T., & Samama, C. M. (2011) · Anesthesiology · doi:10.1097/aln.0b013e318238c036 · Cited by 240
Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation
Kirchhof, P. F., Hæusler, K. G., Blank, B., de Bono, J. P., Callans, D. J., Elvan, A., Fetsch, T., Gelder, I. C. V., Gentlesk, P. J., Grimaldi, M., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy176 · Cited by 240
Inohara, T., Xian, Y., Liang, L., Matsouaka, R., Saver, J. L., Smith, E. E., Schwamm, L. H., Reeves, M. J., Hernandez, A. F., Bhatt, D. L., et al. (2018) · JAMA · doi:10.1001/jama.2017.21917 · Cited by 237
Sandhu, R. K., Ezekowitz, J. A., Andersson, U., Alexander, J. H., Granger, C. B., Halvorsen, S., Hanna, M., Hijazi, Z., Janský, P., Lópes, R. D., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw124 · Cited by 235
Chan, K. E., Giugliano, R. P., Patel, M. R., Abramson, S., Jardine, M., Zhao, S. J., Perkovic, V., Maddux, F. W., & Piccini, J. P. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.02.082 · Cited by 231
Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients
Mavrakanas, T. A., Samer, C. F., Nessim, S. J., Frisch, G., & Lipman, M. L. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016090980 · Cited by 231
Post-stroke seizure and post-stroke epilepsy
Myint, P. K., Staufenberg, E. F. A., & Sabanathan, K. (2006) · Postgraduate Medical Journal · doi:10.1136/pgmj.2005.041426 · Cited by 230
Chan, E. W., Lau, W. C. Y., Leung, W. K., Mok, M. T. C., He, Y., Tong, T. S. M., & Wong, I. C. K. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.002 · Cited by 227
The transport of antiepileptic drugs by P-glycoprotein
Zhang, C., Kwan, P., Zuo, Z., & Baum, L. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.003 · Cited by 224
Flagged first, then by citations
2 of the 558 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Corbalan, 2017, [Features, management and prognosis of Chilean patients with non valvular atrial fibrillation: GARFIELD AF registry], Rev Med Chil, 145, 963
- Kubitza, 2006, No interaction between the novel, oral direct factor Xa inhibitor BAY 59-7939 and digoxin, J Clin Pharmacol, 46, 702
Cited by
Sorted by citations
Lyon, A. R., López‐Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J. K., Boriani, G., Cardinale, D. M., Córdoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,457
Self-citationGelder, I. C. V., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., Potter, T. J. R. D., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,594
Self-citation2024 ESC Guidelines for the management of chronic coronary syndromes
Vrints, C. J., Andreotti, F., Koskinas, K. C., Rosselló, X., Adamo, M., Ainslie, J., BANNING, A. P., Budaj, A., Buechel, R. R., Chiariello, G. A., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae177 · Cited by 3,521
Halvorsen, S., Mehilli, J., Cassese, S., Hall, T. S., Abdelhamid, M., Barbato, E., Hert, S. G. D., de Laval, I., Geisler, T., Hinterbuchner, L., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac270 · Cited by 1,287
Self-citationTzeis, S. E., Gerstenfeld, E. P., Kalman, J. M., Saad, E., Shamloo, A. S., Andrade, J. G., Barbhaiya, C. R., Baykaner, T., Bovéda, S., Calkins, H. G., et al. (2024) · EP Europace · doi:10.1093/europace/euae043 · Cited by 724
Self-citation
Metadata
- Authors
- Steffel, J., Collins, R., Antz, M., Cornu, P., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., Rowell, N., Sinnaeve, P., Vanassche, T., Potpara, T., Camm, A. J., Heidbüchel, H., reviewers, E., Lip, G. Y. H., Deneke, T., Dagres, N., Boriani, G., Chao, T.-F., Choi, E.-K., Hills, M. T., Santos, I. D. S., Lane, D. A., Atar, D., Joung, B., Cole, O. M., & Field, M.
- Affiliations
- University of Zurich (CH)
- Age-Related Health Care, Tallaght University Hospital / Department of Gerontology Trinity College , Dublin,
- Klinikum Braunschweig (DE)
- Vrije Universiteit Brussel (BE)
- University of Antwerp (BE)
- Department of Neurology, Universitätsklinikum Würzburg , Würzburg,
- Uppsala University (SE)
- University Hospital Münster (DE)
- University of Murcia , Murcia,
- Middlesbrough ,
- KU Leuven (BE)
- University of Belgrade (RS)
- St George's, University of London (GB)
- University of Liverpool (GB)
- Rhön-Klinikum (DE)
- University of Modena and Reggio Emilia (IT)
- Seoul National University (KR)
- Universidade de São Paulo (BR)
- Centro de Pesquisa Clínica e Epidemiológica, Hospital Universitário, Universidade de São Paulo , São Paulo,
- Oslo University Hospital (NO)
- Corresponding author
- Steffel, Jan
- ORCID
- Venue
- EP Europace
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-04-25
- Volume
- 23
- Issue
- 10
- Pages
- 1612-1676
- ISSN
- 1099-5129 (ISSN-L)
- 1532-2092
- PMC
- PMC11636576
- OpenAlex
- W3159673032
- Cited by
- 1,132
- References
- 558
- Citations by year
- 2026: 148 · 2025: 179 · 2024: 228 · 2023: 269 · 2022: 224 · 2021: 83
- FWCI
- 134.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- EP Europace (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- Document Server@UHasselt (UHasselt) (submittedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Lirias (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Funders
- Bayer Pharma AG
- Bristol-Myers Squibb
- Pfizer Alliance
- Daiichi-Sankyo Europe GmbH
- NIH
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- direct oral anticoagulants, atrial fibrillation, coronary artery disease, cardioversion, acute stroke, old age, frailty, stroke prevention
- MeSH terms
- Rivaroxaban, Dabigatran, Administration, Oral, Anticoagulants, Atrial Fibrillation, Humans, Pyridones, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
